Table 4 Logistic regression analysis to evaluate the associations between MSI status and clinical factors
Variables | β | OR (95% CI) | P value |
|---|---|---|---|
Gender (female vs male) | 0.520 | 1.682 (0.842–3.360) | 0.141 |
BMI (kg/m2) | 0.158 | 1.171 (1.054–1.301) | 0.003 |
WBC (× 109/L) | 0.142 | 1.152 (1.014–1.310) | 0.030 |
Haemoglobin (g/L) | 0.000 | 1.000 (0.985–1.014) | 0.957 |
Platelet count (× 109/L) | 0.005 | 1.005 (1.001–1.009) | 0.021 |
CEA (ng/ml) | − 0.004 | 0.996 (0.985–1.008) | 0.549 |
AIM (μg/mL) | − 0.646 | 0.524 (0.375–0.731) | < 0.001 |
Tumor size (cm) | |||
(≥ 5.0 vs < 5.0) | 1.178 | 3.249 (1.631–6.474) | 0.001 |
Tumor location | |||
(Proximal vs distal) | 1.203 | 3.330 (1.642–6.752) | 0.001 |
Histological type | |||
(Mucinous vs non-mucinous) | 1.452 | 4.273 (1.974–9.248) | < 0.001 |
Histological grade | |||
(Poorly differentiated vs well/moderately differentiated) | 1.361 | 3.900 (1.881–8.086) | < 0.001 |
Lymphatic invasion | |||
(Presence vs absence) | − 0.695 | 0.499 (0.186–1.339) | 0.168 |
Lymph node metastasis | |||
(Presence vs absence) | 0.629 | 1.875 (0.188–18.671) | 0.592 |
Stage | |||
(III + IV vs I + II) | − 1.863 | 0.155 (0.015–1.600) | 0.118 |